---
title: "NP94023a-d Ellipta Inhalers"
ocid: "ocds-r6ebe6-0000740091"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000740091"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000740091.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000740091.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2023-09-01"
---

# NP94023a-d Ellipta Inhalers

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000740091

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000740091)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000740091.json)

## Summary

The NHS National Services Scotland has completed the procurement of Ellipta Inhalers under the title "NP94023a-d Ellipta Inhalers". The procurement process was initiated through a limited procurement method with an award procedure without prior publication of a call for competition. The buying organisation is based in Edinburgh, UK, and the contract has been awarded to GSK UK Limited. The procurement falls under the goods category and is protected by exclusive rights. The total contract value is £3,605,000, and the contract was signed on 15th August 2023.

This tender for the supply of Ellipta Inhalers to NHS Scotland presents an opportunity for businesses, especially those in the health industry category, to compete. Companies interested in large-scale healthcare supply contracts with a focus on pharmaceuticals would be well-suited to pursue this opportunity. Given the specific requirements and restrictive nature of the procurement process, businesses with expertise in pharmaceutical manufacturing and distribution could find this tender particularly relevant for business growth.

## Notice

Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro(r) Ellipta(r)) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse(r) Ellipta(r)) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Trelegy(r) Ellipta(r))

### Lot Information

Lot 1

The four individual Framework Agreements are for the supply of a range of Ellipta Inhalers to NHS Scotland. Each Framework Agreement has been awarded as a single supplier framework agreement to 1 Framework Participant.

### Procurement Information

The medicines awarded to the individual framework agreements are protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP487358 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 1 Sep 2023 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 Aug 2023 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £3,605,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | GSK |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 1 Sep 2023 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP487358
- 28 Jul 2023 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL484748

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL484748
  NP94023a-d Ellipta Inhalers - Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro(r) Ellipta(r)) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse(r) Ellipta(r)) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Trelegy(r) Ellipta(r))
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP487358
  NP94023a-d Ellipta Inhalers - Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro(r) Ellipta(r)) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse(r) Ellipta(r)) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar(r) Ellipta(r)) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Trelegy(r) Ellipta(r))

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000740091

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000740091. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000740091.json.